circRNADisease v2.0: an updated resource for high-quality experimentally supported circRNA-disease associations
2023 · Nucleic Acids Research · 32 citations
https://doi.org/10.1093/nar/gkad949
C
Changlin Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
1.4K
Citations
17
h-index
23
i10-index
Changlin Yang is an academic researcher from BGI Group (China). The author has contributed to research in topics: Immunotherapy and Immune Responses & Glioma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 17, co-authored 107 publications.
ORCID: 0000-0001-5687-600XPapers by this author
worksTargeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response
2025 · Journal of Clinical Investigation · 3 citations
https://doi.org/10.1172/jci184043
Molecular and clinical characterization of PTRF in glioma via 1,022 samples
2023 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-023-11001-2
Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells
2024 · Molecular Therapy — Methods & Clinical Development · 1 citations
https://doi.org/10.1016/j.omtm.2024.101192
Substituting time spent in physical activity and sedentary time and its association with cardiovascular disease among northwest Chinese adults
2024 · Preventive Medicine Reports · 0 citations
https://doi.org/10.1016/j.pmedr.2024.102934
Wide-spectrum profiling of plasma cell-free RNA and the potential for health-monitoring
2025 · RNA Biology · 0 citations
https://doi.org/10.1080/15476286.2025.2481736
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat